Optimization of trial duration to predict long‐term HbA1c change with therapy: A pharmacometrics simulation‐based evaluation

Abstract Glycated hemoglobin (HbA1c) is the main biomarker of diabetes drug development. However, because of its delayed turnover, trial duration is rarely shorter than 12 weeks, and being able to predict long‐term HbA1c with precision using data from shorter studies would be beneficial. The feasibi...

Full description

Saved in:
Bibliographic Details
Main Authors: Hanna Kunina (Author), Alex Al‐Mashat (Author), Jenny Y. Chien (Author), Parag Garhyan (Author), Maria C. Kjellsson (Author)
Format: Book
Published: Wiley, 2022-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available